期刊
UROLOGY
卷 75, 期 2, 页码 334-339出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.urology.2009.09.051
关键词
-
资金
- GE Healthcare
- Houston Center for Quality of Care & Utilization Studies, Michael E. DeBakey Veterans Affairs Medical Center [HFP 90-020]
Bladder cancer (BlCa) is the fifth most common cancer in the United States and one of the ten deadliest. It ranks fifth among all cancers in total costs, consuming almost $3 billion annually, and has an extensive effect on quality of life for survivors and their families. Despite this human and economic toll, BlCa ranks comparatively low on the national agenda. Our understanding of this disease has grown exponentially over the last decade, paving the way for better prevention, detection, treatment, monitoring, and quality of life. Increasing national attention to BlCa is likely to improve disease burden and patient quality of life. UROLOGY 75: 334-339, 2010. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据